These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 21071344

  • 1. Immunohistochemical detection of dopamine D2 receptors in human pituitary adenomas.
    Pawlikowski M.
    Folia Histochem Cytobiol; 2010 Sep 30; 48(3):394-7. PubMed ID: 21071344
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical detection of PPARgamma receptors in the human pituitary adenomas: correlation with PCNA.
    Winczyk K, Pawlikowski M.
    Folia Histochem Cytobiol; 2005 Sep 30; 43(3):137-41. PubMed ID: 16201313
    [Abstract] [Full Text] [Related]

  • 3. p75 and TrkC neurotrophin receptors demonstrate a different immunoreactivity profile in comparison to TrkA and TrkB receptors in human normal pituitary gland and adenomas.
    Assimakopoulou M, Zolota V, Chondrogianni C, Gatzounis G, Varakis J.
    Neuroendocrinology; 2008 Sep 30; 88(2):127-34. PubMed ID: 18319596
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
    Pirker W, Riedl M, Luger A, Czech T, Rössler K, Asenbaum S, Angelberger P, Kornhuber J, Deecke L, Podreka I, Brücke T.
    J Nucl Med; 1996 Dec 30; 37(12):1931-7. PubMed ID: 8970508
    [Abstract] [Full Text] [Related]

  • 5. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L, Bouligand J, Salenave S, Bernier M, Gaillard S, Parker F, Young J, Guiochon-Mantel A, Chanson P.
    J Clin Endocrinol Metab; 2012 Apr 30; 97(4):E663-70. PubMed ID: 22319033
    [Abstract] [Full Text] [Related]

  • 6. Expression of somatostatin receptor subtypes in human pituitary adenomas -- immunohistochemical studies.
    Pisarek H, Pawlikowski M, Kunert-Radek J, Radek M.
    Endokrynol Pol; 2009 Apr 30; 60(4):240-51. PubMed ID: 19753537
    [Abstract] [Full Text] [Related]

  • 7. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H, Saeger W.
    Eur J Endocrinol; 2006 May 30; 154(5):753-8. PubMed ID: 16645024
    [Abstract] [Full Text] [Related]

  • 8. Estrogen receptors in human pituitary tumors.
    Burdman JA, Pauni M, Heredia Sereno GM, Bordón AE.
    Horm Metab Res; 2008 Aug 30; 40(8):524-7. PubMed ID: 18398784
    [Abstract] [Full Text] [Related]

  • 9. Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.
    Pivonello C, Patalano R, Negri M, Pirchio R, Colao A, Pivonello R, Auriemma RS.
    Front Endocrinol (Lausanne); 2021 Aug 30; 12():791633. PubMed ID: 35095761
    [Abstract] [Full Text] [Related]

  • 10. Neuronal differentiation and expression of neural epitopes in pituitary adenomas.
    Johnson MD, Fan X, Bourne P, Walters D.
    J Histochem Cytochem; 2007 Dec 30; 55(12):1265-71. PubMed ID: 17875653
    [Abstract] [Full Text] [Related]

  • 11. Protein expression of somatostatin receptor 2, somatostatin receptor 5 and dopamine D2 receptor in normal pituitary gland and ACTH-secreting pituitary adenoma in dogs.
    Sato A, Hara Y.
    Res Vet Sci; 2018 Aug 30; 119():61-66. PubMed ID: 29864631
    [Abstract] [Full Text] [Related]

  • 12. Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas.
    Saveanu A, Jaquet P, Brue T, Barlier A.
    Mol Cell Endocrinol; 2008 May 14; 286(1-2):206-13. PubMed ID: 18241980
    [Abstract] [Full Text] [Related]

  • 13. Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression.
    Pellegrini-Bouiller I, Morange-Ramos I, Barlier A, Gunz G, Figarella-Branger D, Cortet-Rudelli C, Grisoli F, Jaquet P, Enjalbert A.
    J Clin Endocrinol Metab; 1996 Sep 14; 81(9):3390-6. PubMed ID: 8784102
    [Abstract] [Full Text] [Related]

  • 14. [Pituitary lactotroph adenomas resistant to dopamine agonist treatment: histological and immunohistochemical characteristics].
    Fedorova NS, Abrosimov AY, Dzeranova LK, Pigarova EA, Dedov II.
    Arkh Patol; 2018 Sep 14; 80(3):34-39. PubMed ID: 29927438
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.
    Luque GM, Perez-Millán MI, Ornstein AM, Cristina C, Becu-Villalobos D.
    J Pharmacol Exp Ther; 2011 Jun 14; 337(3):766-74. PubMed ID: 21406548
    [Abstract] [Full Text] [Related]

  • 16. Characterization of c-kit (CD117) expression in human normal pituitary cells and pituitary adenomas.
    La Rosa S, Uccella S, Dainese L, Marchet S, Placidi C, Vigetti D, Capella C.
    Endocr Pathol; 2008 Jun 14; 19(2):104-11. PubMed ID: 18568298
    [Abstract] [Full Text] [Related]

  • 17. Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas.
    Gabalec F, Beranek M, Netuka D, Masopust V, Nahlovsky J, Cesak T, Marek J, Cap J.
    Pituitary; 2012 Jun 14; 15(2):222-6. PubMed ID: 21597974
    [Abstract] [Full Text] [Related]

  • 18. Expression pattern of neuronal intermediate filament α-internexin in anterior pituitary gland and related tumors.
    Schult D, Hölsken A, Buchfelder M, Schlaffer SM, Siegel S, Kreitschmann-Andermahr I, Fahlbusch R, Buslei R.
    Pituitary; 2015 Aug 14; 18(4):465-73. PubMed ID: 25236435
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.